Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 2,475.00
+5.50 (0.22%)
Jul 10, 2026, 3:29 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 408.5 billion as of July 10, 2026. Its market cap has increased by 45.23% in one year.
Market Cap
408.50B
Enterprise Value
377.00B
Revenue
64.31B
Ranking
n/a
PE Ratio
39.81
Stock Price
2,475.00
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has increased from 297.10B to 408.50B, an increase of 37.49%. That is a compound annual growth rate of 5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 408.50B | 43.98% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurobindo Pharma | 900.29B |
| Laurus Labs | 830.19B |
| Alkem Laboratories | 677.79B |
| Glenmark Pharmaceuticals | 644.24B |
| Ipca Laboratories | 453.60B |
| Ajanta Pharma | 418.20B |
| Emcure Pharmaceuticals | 343.99B |
| Wockhardt | 294.22B |